NCT04068298

Brief Summary

The assessment and treatment of Septic Shock (SS) is a thorny issue in current care. Fluid resuscitation is one of the key measures for SS treatment. Current fluid resuscitation is dominated by empirical treatment or early target-directed therapy. The former has a clear goal of recovery, and the latter is complicated to implement and has many complications. It is known that patients with SS due to insufficient tissue perfusion, the distribution of blood flow in the peripheral center to the center, may lead to an increase in the central-peripheral-room temperature difference, suggesting that this index has potential value for direction of fluid resuscitation. This study intends to measure the severity of SS and efficacy of fluid resuscitation by measuring the "central-peripheral-room temperature" gradient of patients as well as comparing temperature gradient with hemodynamic indexes (PICCO) and indexes of ultrasound capacity assessment, providing more convenient indicators for sepsis and fluid resuscitation assessment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
205

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 22, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 28, 2019

Completed
4 days until next milestone

Study Start

First participant enrolled

September 1, 2019

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2022

Completed
Last Updated

August 28, 2019

Status Verified

August 1, 2019

Enrollment Period

3 years

First QC Date

August 22, 2019

Last Update Submit

August 25, 2019

Conditions

Keywords

sepsistemperature gradientmicrocirculation

Outcome Measures

Primary Outcomes (1)

  • 28-day mortality

    Rate of all-caused mortality at 28 days

    three years

Secondary Outcomes (2)

  • ICU Length of stay

    three years

  • Hospital Length of stay

    three years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study subjects were patients with sepsis and/or septic shock in the Department of Critical Care Medicine, Southern Hospital from September 2019 to September 2022.

You may qualify if:

  • Older than 17 years old.
  • Patients with sepsis or septic shock who meet the diagnostic criteria for sepsis 3.0 and who are routinely treated according to 《Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016》.
  • Get informed consent within 2 hours.

You may not qualify if:

  • Age \<18 years old.
  • A confirmed pregnancy or urine pregnancy test is positive.
  • Patients with septic shock at low temperature (central body temperature \<35 °C).
  • The informed consent of the legal representative of the subject was not obtained.
  • Known liver disease affecting peripheral perfusion assessment, such as vascular occlusive vasculitis, multiple arteritis, and Raynaud's disease.
  • Any disease that restricts the use of fluid resuscitation, such as: heart failure, major cardiac surgery, post-cardiopulmonary resuscitation, severe heart disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NanFang hospital

Guangzhou, Guangdong, 510515, China

RECRUITING

MeSH Terms

Conditions

Sepsis

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 22, 2019

First Posted

August 28, 2019

Study Start

September 1, 2019

Primary Completion

September 1, 2022

Study Completion

September 1, 2022

Last Updated

August 28, 2019

Record last verified: 2019-08

Locations